272 Capital’s Anterix ATEX Stock Holding History

272 Capital’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-52,308	Closed	-$2.07M	–	62
2024 Q2	$2.07M	Sell	52,308 -9,370	-15%	-$303K	1.04%	36
2024 Q1	$2.07M	Buy	+61,678	New	+$2.07M	0.83%	36

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

272 Capital's ATEX Position: Q3 2024 in Review

272 Capital sold out of Anterix (ATEX) in Q3 2024, closing a stake of 52,308 shares — an estimated $2.07M sold.

272 Capital first reported a position in ATEX in Q1 2024 and held it in 2 quarters. The position peaked at $2.07M in Q1 2024. 129 funds tracked by Wall St. Rank hold ATEX as of Q3 2024.

272 Capital reported no remaining Anterix position as of Q3 2024 after selling out during the quarter.
272 Capital sold 52,308 Anterix shares in Q3 2024, an estimated $2.07M.
272 Capital first reported a position in Anterix in Q1 2024 and held it in 2 quarters.
272 Capital's Anterix position peaked at $2.07M in Q1 2024.
129 funds tracked by Wall St. Rank held Anterix as of Q3 2024.

Based on 272 Capital's 13F filing for Q3 2024, filed 14 Nov 2024.